These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35670308)

  • 1. Derivation and validation of a risk classification tree for patients with synovial sarcoma.
    Neel DV; Ma C; Collins NB; Hornick JL; Demetri GD; Shulman DS
    Cancer Med; 2023 Jan; 12(1):170-178. PubMed ID: 35670308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
    Jacobs AJ; Morris CD; Levin AS
    Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
    Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications.
    Waxweiler TV; Rusthoven CG; Proper MS; Cost CR; Cost NG; Donaldson N; Garrington T; Greffe BS; Heare T; Macy ME; Liu AK
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):339-48. PubMed ID: 25968827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients.
    Sultan I; Rodriguez-Galindo C; Saab R; Yasir S; Casanova M; Ferrari A
    Cancer; 2009 Aug; 115(15):3537-47. PubMed ID: 19514087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of tumor-size-stratified prognostic nomograms for patients with uterine sarcoma: A SEER database analysis.
    Cao S; Liao X; Xu K; Xiao H; Shi Z; Zou Y; Li C; Hu Y; Yan S
    Cancer Med; 2023 Jan; 12(2):1339-1349. PubMed ID: 35841316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis.
    Naing KW; Monjazeb AM; Li CS; Lee LY; Yang A; Borys D; Canter RJ
    J Surg Oncol; 2015 Feb; 111(2):158-64. PubMed ID: 25176165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of conditional treatment effects of adjuvant treatments on patients with synovial sarcoma using Bayesian subgroup analysis.
    Seo SW; Kim J; Son J; Lim S
    BMC Med Inform Decis Mak; 2020 Dec; 20(1):320. PubMed ID: 33272256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, incidence, and survival of synovial sarcoma subtypes: SEER database analysis.
    Aytekin MN; Öztürk R; Amer K; Yapar A
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020936009. PubMed ID: 32618221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The survival and prognosis analysis of synovial sarcoma subtypes: a Surveillance, Epidemiology, and End Results population-based analysis.
    Xiong L; Chen Z; Zhou Y; Li H; Xiao T
    Int Orthop; 2020 Dec; 44(12):2779-2786. PubMed ID: 32880003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Discrete Prognostic Groups in Ewing Sarcoma.
    Karski EE; McIlvaine E; Segal MR; Krailo M; Grier HE; Granowetter L; Womer RB; Meyers PA; Felgenhauer J; Marina N; DuBois SG
    Pediatr Blood Cancer; 2016 Jan; 63(1):47-53. PubMed ID: 26257296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Survival in Patients With Synovial Cell Sarcoma of the Head and Neck: An Analysis of 167 Cases Using the SEER (Surveillance, Epidemiology, and End Results) Database.
    Mallen-St Clair J; Arshi A; Abemayor E; St John M
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):576-83. PubMed ID: 27100936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
    ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).
    Ferrari A; De Salvo GL; Brennan B; van Noesel MM; De Paoli A; Casanova M; Francotte N; Kelsey A; Alaggio R; Oberlin O; Carli M; Ben-Arush M; Bergeron C; Merks JH; Jenney M; Stevens MC; Bisogno G; Orbach D
    Ann Oncol; 2015 Mar; 26(3):567-72. PubMed ID: 25488687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial sarcoma: identification of low and high risk groups.
    Bergh P; Meis-Kindblom JM; Gherlinzoni F; Berlin O; Bacchini P; Bertoni F; Gunterberg B; Kindblom LG
    Cancer; 1999 Jun; 85(12):2596-607. PubMed ID: 10375108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
    Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
    Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
    Smartt AA; Jang ES; Tyler WK
    Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma.
    Song Z; Cheng L; Lu L; Lu W; Zhou Y; Wang Z
    Front Endocrinol (Lausanne); 2021; 12():764571. PubMed ID: 35308782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical outcomes and prognostic factors for synovial sarcoma arising from the extremities.
    Sakabe T; Murata H; Konishi E; Takeshita H; Ueda H; Matsui T; Horie N; Yanagisawa A; Kubo T
    Med Sci Monit; 2008 Jun; 14(6):CR305-310. PubMed ID: 18509273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database.
    Duchman KR; Gao Y; Miller BJ
    Cancer Epidemiol; 2015 Apr; 39(2):189-95. PubMed ID: 25595632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.